Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2023-04-03 Proxy Solicitation & In…
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Postal Ballot Notice ('Notice') seeking the approval of the members of the Company.
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Postal Ballot Notice dated April 3, 2023, from Unichem Laboratories Limited. It seeks shareholder approval for the appointment of a Non-Executive Independent Director. The document references the Companies Act, SEBI Listing Regulations, and details the voting process including remote e-voting instructions, voting period, and the role of the Scrutinizer. It is a notice sent to shareholders to solicit votes on a specific resolution, not the announcement of voting results or the results themselves. It does not contain financial statements or management discussion but is focused on governance matters related to board appointments. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or resolutions.
2023-04-03 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice from Unichem Laboratories Limited addressed to stock exchanges regarding the closure of the trading window for insiders and designated persons. It references compliance with insider trading regulations and specifies the trading window closure period around the financial results announcement date. The document is short (1455 characters) and is a regulatory announcement related to trading restrictions, not a financial report or detailed filing. It does not contain financial data, management discussion, or voting results. Therefore, it fits best under Regulatory Filings (RNS) as a compliance-related announcement.
2023-03-31 English
Notice of trading window close.
Regulatory Filings Classification · 95% confidence The document is a notice regarding the closure of the trading window for insiders and designated persons in compliance with insider trading regulations. It references the upcoming financial results for the quarter and year ended March 31, 2023, but does not contain any financial data or results itself. The document is short (1455 characters) and serves as an announcement related to trading restrictions rather than a financial report or detailed filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or any other detailed financial or management report. It is also not a certification or legal proceeding. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-03-31 English
Board of Directors Update
Board/Management Information Classification · 100% confidence The document is a formal announcement addressed to stock exchanges regarding changes in the company's board of directors. It details the cessation of an independent director's term and the appointment of a new independent director, including their profiles and committee assignments. There are no financial statements, earnings data, or report attachments. The content focuses solely on board updates and governance changes. Therefore, this fits the category of Board/Management Information (MANG). The document length and detail support a confident classification.
2023-03-20 English
Outcome of Board Meeting
Board/Management Information Classification · 100% confidence The document is a formal announcement addressed to stock exchanges regarding changes in the company's board of directors. It details the cessation of an independent director's term and the appointment of a new independent director, including their profiles and committee assignments. There are no financial statements, earnings data, or report attachments. The content focuses solely on board updates and governance changes. Therefore, this fits the category of Board/Management Information (MANG). The document length and content confirm it is not a brief announcement or a report publication notice but a substantive disclosure of management changes.
2023-03-20 English
Press release pertaining to the receipt of ANDA approval from the United States Food and Drug Administration (USFDA) for Unichem's Ranolazine Extended-Release Tablets, 500 mg, and 1000 mg.
Regulatory Filings Classification · 95% confidence The document is a press release announcing the receipt of ANDA approval from the USFDA for Unichem Laboratories' Ranolazine Extended-Release Tablets. It is an update on a regulatory approval event rather than a financial report, management discussion, or shareholder meeting material. The document is relatively short (3415 characters) and serves as a notification to stock exchanges under SEBI regulations. It does not contain financial statements, earnings data, or detailed management analysis. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance-related disclosures that do not fit other specific categories.
2023-03-17 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.